Perfuse Therapeutics Shares Promising Phase IIa Results in Glaucoma and Diabetic Retinopathy
Could better blood flow be the key to treating glaucoma and diabetic retinopathy? New findings suggest it just might. Sometimes…
Intalight’s DREAM OCT Platform Cleared for EU Market with CE Mark
DREAM OCT scans from cornea to vitreous in one single scan, enabling full anterior segment imaging. Intalight (Shanghai, China), a…
latest posts